# EDGAR Filing Document

**Accession Number:** 0001102942
**File Stem:** 0001493152-23-005655
**Filing Date:** 2023-2
**Character Count:** 5574
**Document Hash:** d4a4a0472d096d94bf1f23978077878c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-005655.hdr.sgml**: 20230221

**ACCESSION NUMBER**: 0001493152-23-005655

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20220927

**FILED AS OF DATE**: 20230221

**DATE AS OF CHANGE**: 20230221

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Dab Gerard
- **CENTRAL INDEX KEY:** 0001305442

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-33191
- **FILM NUMBER:** 23648318

**MAIL ADDRESS:**
- **STREET 1:** 391A LAURIER WEST
- **CITY:** MONTREAL
- **STATE:** A8
- **ZIP:** H2V 2K3
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** InnovaQor, Inc.
- **CENTRAL INDEX KEY:** 0001102942
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
- **IRS NUMBER:** 880436055
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 400 SOUTH AUSTRALIAN AVENUE
- **STREET 2:** SUITE 800
- **CITY:** WEST PALM BEACH
- **STATE:** FL
- **ZIP:** 33401
- **BUSINESS PHONE:** (514) 274-1115

**MAIL ADDRESS:**
- **STREET 1:** 400 SOUTH AUSTRALIAN AVENUE
- **STREET 2:** SUITE 800
- **CITY:** WEST PALM BEACH
- **STATE:** FL
- **ZIP:** 33401

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VisualMED Clinical Solutions Corp.
- **DATE OF NAME CHANGE:** 20050107

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VisualMED Clinical Systems Corp.
- **DATE OF NAME CHANGE:** 20050106

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ANCONA MINING CORP
- **DATE OF NAME CHANGE:** 20000111

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Dab Gerard<br><sub>(Last) (First) (Middle)</sub><br>400 S. AUSTRALIAN AVE.,<br>SUITE 800<br><sub>(Street)</sub><br>WEST PALM BEACH,, FL 33401<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>InnovaQor, Inc. [ INQR ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2022-09-27 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

**Remarks:**
Gerard Dab owns 200 shares of Series C-1 Convertible Redeemable Preferred Stock (the "Series C-1 Preferred Stock") of InnovaQor, Inc. The Series C-1 Preferred Stock has a stated value of $1,000 per share and is convertible into the number of shares of Common Stock determined by dividing the stated value of the shares being converted by the conversion price, which equals 90% of the average closing price of the Common Stock on the 10 trading days immediately prior to the conversion date. If the conversion date were September 26, 2022, the 200 shares of Series C-1 Preferred Stock would have been convertible into 11,724,168 shares of Common Stock, due to the 4.99% ownership blocker in the terms of the Series C-1 Preferred Stock. If there were no ownership blocker, the 200 shares of Series C-1 Preferred Stock would have been convertible into 36,133,694 shares of Common Stock as of September 26, 2022. Because the conversion price of the Series C-1 Preferred Stock is determined based on the market price of the Common Stock, the number of shares of Common Stock into which the Series C-1 Preferred Stock is convertible will fluctuate.

**Signature:** /s/ Gerard Dab  
**Date:** 2023-02-21

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**